A patient taking olanzapine 10 mg wishes to start seroquel (quetiapine); can olanzapine be stopped?

Switching from Olanzapine to Quetiapine

You should not abruptly stop olanzapine 10mg when switching to quetiapine (Seroquel); instead, perform a gradual cross-titration over several days to weeks to minimize withdrawal symptoms and prevent psychotic relapse.

Switching Strategy

The safest approach involves gradual cross-titration rather than abrupt discontinuation 1. While abrupt switching to quetiapine has been studied and does not produce significant clinical consequences in research settings 2, real-world clinical practice demands a more cautious approach to minimize risks.

Recommended Cross-Titration Approach:

Start quetiapine while gradually reducing olanzapine:

• Day 1-2: Begin quetiapine 50mg BID while continuing olanzapine 10mg
• Day 3-4: Increase quetiapine to 100mg BID, reduce olanzapine to 7.5mg
• Day 5-7: Increase quetiapine to 200mg BID, reduce olanzapine to 5mg
• Day 8-10: Increase quetiapine to 300mg BID, reduce olanzapine to 2.5mg
• Day 11+: Discontinue olanzapine, continue quetiapine titration toward target dose of 400mg/day (can range 150-750mg/day based on response) 2

This gradual approach accounts for the different receptor profiles and half-lives of these medications 3.

Critical Considerations

Why Gradual Switching Matters:

Withdrawal risks from abrupt olanzapine discontinuation include:

• Psychotic relapse (occurs in most patients with psychotic disorders when antipsychotics are stopped) 1
• Withdrawal symptoms: insomnia, nausea, vomiting 4
• Rebound symptoms that may emerge weeks to months after stopping 1

Quetiapine has distinct properties compared to olanzapine:

• More sedating 3, 5, 3
• Less likely to cause extrapyramidal symptoms 3
• May cause orthostatic hypotension and dizziness 3
• Requires BID dosing (oral route only) 3

Monitoring During the Switch:

• Blood pressure: Check for orthostatic hypotension, especially during initial titration 4
• Sedation/falls risk: Quetiapine is more sedating than olanzapine; warn about driving and operating machinery 5, 4
• Psychotic symptoms: Monitor closely for breakthrough symptoms during cross-titration
• Metabolic parameters: Both medications affect weight and glucose, though profiles differ 4

Important Caveats:

Quetiapine may be less effective than olanzapine for some patients. In head-to-head comparisons, olanzapine demonstrated longer time to discontinuation and better efficacy in symptomatic schizophrenia patients 6, 7. When patients discontinued a previous atypical antipsychotic due to inefficacy, olanzapine was more effective than quetiapine 7.

Dose equivalency considerations: The patient's olanzapine 10mg dose is at the upper end of typical dosing 5. Quetiapine doses of 400-600mg/day may be needed for equivalent antipsychotic effect, though direct dose equivalencies between these agents are imprecise 6, 2.

Special populations:

• Reduce doses in elderly or hepatically impaired patients 3
• In older patients, start quetiapine at 12.5mg BID 5

Patient Education:

Inform the patient to expect:

• Increased sedation initially with quetiapine 5, 4
• Possible dizziness upon standing 4
• Need for twice-daily dosing
• Importance of not stopping medications abruptly 4, 1

The switch should be individualized based on the patient's specific indication (schizophrenia, bipolar disorder, other), current symptom control, prior medication responses, and tolerability concerns. If the patient is switching due to olanzapine's metabolic side effects, quetiapine offers only modest advantages as both cause weight gain and metabolic disturbances 4, 8.